National Heart Lung and Blood Institute of NIH awards Grand Opportunities grant to BMC

October 05, 2017

???UMass Medical School was a national leader in adopting i2b2 as part of our MICARD translational research project,??? said Ralph Zottola, PhD, Associate CIO, UMass Medical School. ???i2b2 presents a radical advance in the ability to use clinical data for translational research and disparities monitoring while adhering to the utmost privacy protection for patients.???

Recombinant Data Corp., the commercial support provider for the i2b2 platform, specializes in the tools and techniques necessary to integrate and de-identify healthcare data from disparate source systems into data warehouses for secondary use and analytics.

???Recombinant is pleased to support BMC and UMMS in this ground-breaking disparities research project,??? stated Peter Emerson, CEO, Recombinant Data Corp. ???Having previously implemented i2b2 at each institution, we have a significant head start in delivering the expert technical assistance required to ensure this unique research collaboration succeeds.???